Wei Xue
21PUBLICATIONS
62CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (21)
Sort by Publication Date:
|Feb 23, 2026
SLC25A37 as a novel therapeutic target for benign prostatic hyperplasia: integrative analyses of single-cell RNA sequencing and genome-wide association studies.Zhen Tong, Wei Zhang, Xinrui Wu
|Feb 17, 2026
Distinct prognostic value of [18F]FDG PET and [68Ga]Ga-PSMA-11 PET in advanced hormone-sensitive prostate cancer.Ang Li, Haotian Wu, Xiang Zhou
|Jan 28, 2026
Targeting GNG4 inhibits tumor progression and restores enzalutamide sensitivity in prostate cancer by suppressing autophagy.Lei Chen, Jingyan Zhang, Yanshuo Hu
|Dec 19, 2025
Serotonin Modulates Lineage Plasticity in Neuroendocrine Prostate Cancer via Epigenetic Reprogramming.Yiyi Ji, Cheng-Wei Ju, Lei Chen
|Nov 03, 2024
Efficacy and Predictive Factors Analysis of Androgen Deprivation Plus Novel Hormone Therapy as Neoadjuvant Treatment for High-Risk Prostate Cancer.Hanyang Tao, Fan Wu, Rui Li
|Oct 19, 2024
Iron-loaded cancer-associated fibroblasts induce immunosuppression in prostate cancer.Kai Zhang, Kaiyuan Liu, Benxia Hu
Pageof 4
![Automated Preparation of [<sup>68</sup>Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F68356.jpg&w=3840&q=75)
